Seres Therapeutics Inc

XNAS:MCRB

7.32

-0.26 (-3.43%)

4:10:05 PM EDT: $7.32 0.00 (0.00%)

Market Cap (Intraday)	68.45M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.36 Million
Adjusted EPS	-$2.30

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Seres Therapeutics Inc Stock, XNAS:MCRB

101 Cambridge Park Drive, 4th floor, Cambridge, Massachusetts 02140

United States of America

Phone: +1.617.945.9626

Number of Employees: 233

http://www.serestherapeutics.com

Description

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.